A parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy for cervical cancer
Abstract Forty-nine patients with stage IIb cervical cancer were included to investigate the changes in bladder volume in response to different approaches to maintaining consistent bladder filling. The impacts of age (P age), water consumption (P wat ), and body mass index (BMI, P bmi ) on the mean...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/556d01ccd9cf4f28a45dd49e1128e67e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:556d01ccd9cf4f28a45dd49e1128e67e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:556d01ccd9cf4f28a45dd49e1128e67e2021-12-02T12:32:15ZA parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy for cervical cancer10.1038/s41598-017-00356-92045-2322https://doaj.org/article/556d01ccd9cf4f28a45dd49e1128e67e2017-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00356-9https://doaj.org/toc/2045-2322Abstract Forty-nine patients with stage IIb cervical cancer were included to investigate the changes in bladder volume in response to different approaches to maintaining consistent bladder filling. The impacts of age (P age), water consumption (P wat ), and body mass index (BMI, P bmi ) on the mean urinary inflow rate (v tot ) were analysed. The bladder volume (BV) increased linearly over time. A large variation in v tot among individuals was observed, ranging from 0.19 to 5.13 ml/min. The v tot was correlated with P age (R = −0.53, p = 0.01) and P wat (R = 0.84, p = 0.00), and no correlation between v tot and P bmi was found (p > 0.05). Therefore, v tot could be parameterized using two methods: multivariable linear regression and iterative fitting. There was no statistically significant difference between the two methods. The model accuracy was successfully assessed with several validation tests for patients with good compliance (79.2% of all patients), and the proportion of radiotherapy (RT) fractions with zero wait time (one ultrasound (US) scan) increased from 6.5% to 41.2%. The optimal US scanning number and RT time could be provided using this model. This adaptive RT approach could reduce patient discomfort caused by holding onto urine and reduce technician labour as well as cost.Fu JinHuan-Li LuoJuan ZhouDing-Yi YangLi YinXiao-Qing YangYa-Nan HeXian-Feng LiuDa QiuMing-Song ZhongHan YangChao LiQi-Cheng LiGuang-Lei HeYing WangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-7 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Fu Jin Huan-Li Luo Juan Zhou Ding-Yi Yang Li Yin Xiao-Qing Yang Ya-Nan He Xian-Feng Liu Da Qiu Ming-Song Zhong Han Yang Chao Li Qi-Cheng Li Guang-Lei He Ying Wang A parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy for cervical cancer |
description |
Abstract Forty-nine patients with stage IIb cervical cancer were included to investigate the changes in bladder volume in response to different approaches to maintaining consistent bladder filling. The impacts of age (P age), water consumption (P wat ), and body mass index (BMI, P bmi ) on the mean urinary inflow rate (v tot ) were analysed. The bladder volume (BV) increased linearly over time. A large variation in v tot among individuals was observed, ranging from 0.19 to 5.13 ml/min. The v tot was correlated with P age (R = −0.53, p = 0.01) and P wat (R = 0.84, p = 0.00), and no correlation between v tot and P bmi was found (p > 0.05). Therefore, v tot could be parameterized using two methods: multivariable linear regression and iterative fitting. There was no statistically significant difference between the two methods. The model accuracy was successfully assessed with several validation tests for patients with good compliance (79.2% of all patients), and the proportion of radiotherapy (RT) fractions with zero wait time (one ultrasound (US) scan) increased from 6.5% to 41.2%. The optimal US scanning number and RT time could be provided using this model. This adaptive RT approach could reduce patient discomfort caused by holding onto urine and reduce technician labour as well as cost. |
format |
article |
author |
Fu Jin Huan-Li Luo Juan Zhou Ding-Yi Yang Li Yin Xiao-Qing Yang Ya-Nan He Xian-Feng Liu Da Qiu Ming-Song Zhong Han Yang Chao Li Qi-Cheng Li Guang-Lei He Ying Wang |
author_facet |
Fu Jin Huan-Li Luo Juan Zhou Ding-Yi Yang Li Yin Xiao-Qing Yang Ya-Nan He Xian-Feng Liu Da Qiu Ming-Song Zhong Han Yang Chao Li Qi-Cheng Li Guang-Lei He Ying Wang |
author_sort |
Fu Jin |
title |
A parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy for cervical cancer |
title_short |
A parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy for cervical cancer |
title_full |
A parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy for cervical cancer |
title_fullStr |
A parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy for cervical cancer |
title_full_unstemmed |
A parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy for cervical cancer |
title_sort |
parameterized model for mean urinary inflow rate and its preliminary application in radiotherapy for cervical cancer |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/556d01ccd9cf4f28a45dd49e1128e67e |
work_keys_str_mv |
AT fujin aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT huanliluo aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT juanzhou aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT dingyiyang aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT liyin aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT xiaoqingyang aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT yananhe aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT xianfengliu aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT daqiu aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT mingsongzhong aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT hanyang aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT chaoli aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT qichengli aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT guangleihe aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT yingwang aparameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT fujin parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT huanliluo parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT juanzhou parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT dingyiyang parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT liyin parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT xiaoqingyang parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT yananhe parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT xianfengliu parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT daqiu parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT mingsongzhong parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT hanyang parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT chaoli parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT qichengli parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT guangleihe parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer AT yingwang parameterizedmodelformeanurinaryinflowrateanditspreliminaryapplicationinradiotherapyforcervicalcancer |
_version_ |
1718394156560154624 |